Compliance & Medical Disclaimer
This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.
IMPORTANT: This compound is currently on the World Anti-Doping Agency (WADA) prohibited list. Competitive athletes face sanctions for use including in retirement testing programs. Verify current WADA status with your sport's governing body before any research involvement.
Editorial policy
Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.
Medical Disclaimer
For informational and educational purposes only. Not FDA-approved for human use. Consult a licensed healthcare professional. See full disclaimer.
Standard hexarelin cycle: 8-12 weeks on, 4-8 weeks off. Typical protocol: weeks 1-4 at 50-100 mcg once daily, weeks 5-12 escalate to 100-200 mcg twice daily. Some advanced users pulse-cycle (2 weeks on, 1 week off) to slow desensitization. Cycling essential to maintain receptor sensitivity and prevent tolerance. Without breaks, effectiveness plateaus by week 4-5.
Standard 12-Week Cycle Structure
Weeks 1-4: introduction phase. 50-100 mcg hexarelin once daily (preferably morning) to assess tolerance. Most users tolerate well at low dose; appetite stimulation manageable. GH elevation adequate for early adaptation without overwhelming side effects. By week 4, user can accurately assess personal responsiveness and tolerance for dose escalation.
Weeks 5-8: escalation phase. Increase to 100-150 mcg twice daily (morning/afternoon) based on week 1-4 tolerance. This phase produces maximal anabolic response; muscle gain and fat loss accelerate. GH elevation peaks; IGF-1 reaches 15-20% above baseline. Appetite and cortisol elevation peak during this window; users must manage carefully.
Weeks 9-12: maintenance phase. Continue 100-150 mcg twice daily (some users add third injection 50-100 mcg evening). Anabolic rate slows slightly as receptor desensitization begins despite cycling. Final weeks consolidate gains. Training recovery remains excellent; strength continues improving though at slower rate than week 5-8 peak.
Off-Cycle Period (4-8 Weeks)
Complete cessation of hexarelin. Some users experience brief GH suppression (rebound effect) weeks 1-2 post-cycle, lasting 1-2 weeks before baseline normalizes. Off-cycle allows complete GHS-R1a receptor resensitization and hormonal normalization. Gained muscle is retained with maintained training/nutrition. Off-cycle duration influences next cycle responsiveness: 4 weeks partial resensitization, 8 weeks complete resensitization. Standard recommendation: minimum 4 weeks off, 6-8 weeks preferred.
Pulse-Cycling Alternative
Advanced users sometimes implement pulse-cycling: 2 weeks hexarelin use, 1 week complete break, repeating 3-4 cycles within 8-12 week total duration. Theory: weekly breaks slow receptor desensitization, extending cycle effectiveness. Experience suggests modest slowing of plateau but doesn't prevent desensitization entirely. Pulse-cycling adds complexity; standard continuous cycling remains most researched.
Dose Progression During Cycle
Week 1-2: 50 mcg once daily. Week 3-4: 100 mcg once daily. Week 5-8: 100-150 mcg twice daily. Week 9-12: 150-200 mcg twice daily OR 100-150 mcg twice daily + 50-100 mcg evening. Total daily dose range: week 1-4 (50-100 mcg), weeks 5-12 (200-400 mcg). Dose escalation allows tolerance assessment while minimizing early side effects.
Cycling Rationale
Continuous hexarelin use beyond 12 weeks produces GHS-R1a receptor downregulation and reduced GH responsiveness. Peak GH response may decline 20-40% by week 10-12 despite maintained dosing. Off-cycle periods allow complete receptor resensitization and restoration of baseline GH responsiveness. Cycling prevents the escalating tolerance that makes year-round continuous use progressively ineffective, requiring increasingly higher doses to maintain response.
Multi-Cycle Strategy
Users typically implement 2-4 consecutive cycles yearly (12 weeks on, 6-8 weeks off rotation). This allows cumulative gains across multiple cycles while maintaining GH responsiveness through proper cycling. A user completing 3 cycles yearly achieves 30-40 weeks hexarelin exposure (maintaining good responsiveness throughout) vs continuous use that loses effectiveness by month 3-4. Multi-cycle strategy optimizes long-term results.
Trusted Research-Grade Sources
Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).
Particle Peptides
Independently HPLC-tested, transparent COAs, comprehensive product range.
Browse Particle Peptides →Limitless Life Nootropics
Premium research peptides with strong customer support and verified purity.
Browse Limitless Life →FAQ: Hexarelin Cycling
What happens if I cycle too frequently (less than 4 weeks off)?
Incomplete receptor resensitization. Subsequent cycle responsiveness is reduced vs properly rested cycles. First dose of next cycle produces less dramatic GH elevation. Standard 4-8 week off periods prevent this.
Can I do multiple back-to-back cycles without breaks?
Not recommended. Continuous use beyond 12 weeks produces tolerance plateau. Off-cycle breaks essential for receptor resensitization and sustained effectiveness.
Is 8 weeks off-cycle necessary or will 4 weeks work?
4 weeks provides partial resensitization. 8 weeks provides complete resensitization. 6-8 weeks is optimal balance between off-time and back-to-cycle readiness.
Can I use hexarelin year-round if I pulse-cycle?
Pulse-cycling (1-2 days off per week) slows desensitization but doesn't prevent it. Year-round continuous even with pulse-cycling is not recommended; multi-cycle approach (12 weeks on, 6-8 weeks off) is safer long-term strategy.
User Experiences and Real-World Results?
Users consistently report positive outcomes from this peptide, with improvements visible across multiple metrics. Individual experiences vary based on baseline health, age, training intensity, and supplementation. Benefits emerge within days to weeks, with peak effects developing over the full cycle period.
Community feedback aggregates hundreds of experiences showing consistent patterns. These real-world outcomes align with clinical research findings. User communities on Reddit and peptide forums share detailed tracking and results documentation.
Long-term user experiences show cumulative benefits across multiple cycles. First-time users expect modest benefits; experienced users achieve more dramatic results through protocol optimization.